The initial allocation of seats for Nobel Biocare’s 2016 Global Symposium in New York has been filled. Nobel Biocare will welcome over 2,000 dental professionals to the event, which takes place June 23–26 at the iconic Waldorf Astoria Hotel in New York City, US.
Given the high demand, a limited number of additional places have been made available, though they are expected to fill up quickly. Those who wish to attend the event should visit nobelbiocare.com/global-symposium-2016 or contact their local Nobel Biocare representative as soon as possible.
Under the banner “Where innovation comes to life,” participants will experience a program that combines lectures and master classes from world-renowned speakers with practical hands-on training in the latest techniques in implant dentistry. Attendees will also discover the new innovative additions to Nobel Biocare’s range of products and solutions.
The four-day program is divided into three main themes, each...
Read More 2 minute read
As of January 1, Hans Geiselhöringer has taken over as President of Nobel Biocare. The appointment was made to strengthen the organization around its strategic goals.
Since 2011 Hans Geiselhöringer has served as Executive Vice President of Global Research, Products and Development, shaping a highly competitive product and innovation pipeline. Prior to that he was Executive Vice President Global Marketing and Products from 2010–2011 and Head of NobelProcera and Guided Surgery from 2009–2010. Hans joined Nobel Biocare as Head of NobelProcera in 2008 and was appointed a member of the executive committee in 2009.
From 2004 to 2009, Hans acted as a Global Speaker for Nobel Biocare and with this appointment; he becomes the first Nobel Biocare customer and dental expert in the company’s history to take the reigns as its highest ranking executive. In 1998, he founded DentalX GmbH, a leading dental laboratory chain specializing in implantology, anaplastology,...
Read More 1 minute read
Nobel Biocare has always been and continues to be in full compliance with the FDA regulation and NADL recommendations when producing individualized implant prosthetics. The recent communication from NADL with an important FDA Alert regarding the use of CAD/CAM for in-lab milling of implant abutments does not affect any Nobel Biocare products. Our NobelProcera manufacturing facility in Mahwah, New Jersey is registered as a Medical Device Manufacturer. In addition we have FDA 510(k) clearance on all implants and abutments we currently offer for purchase. We are committed to offering individualized implant prosthetics for a wide range of implant systems that are regulatory compliant and industry leading in quality. For labs that do not work exclusively with NobelProcera, we understand that this news may affect their existing workflows. If that’s the case, we’re here to help. As the pioneer in CAD/CAM dentistry we have over 30 years’ success in CAD/CAM restorations...
Read More 1 minute read
- March 2013
Nobel Biocare Launches New Third-party CAD/CAM Abutments, Implant Bars; Announces New Scanner and 3Shape™ Partnership
• New options for NobelProcera® Abutments on Biomet 3i™, Camlog® and Zimmer® implant platforms
• More restorative flexibility with NobelProcera® Implant Bars on Straumann® implant platforms
• Announcing direct access to unrivaled products with upcoming NobelProcera® 2G Scanner
• New partnership with 3Shape™ will offer open access to NobelProcera® Abutments
• Expert LMT panel discussion and industry-leading speakers focus on major lab and CAD/CAM topics
Nobel Biocare presents its latest innovations in dental implant-based CAD/CAM solutions in Chicago as the
"Windy City" hosts both the 148th Chicago Dental Society "Midwinter Meeting," 21-23 February, and one of the largest international gatherings of the dental laboratory community in the world, the LMT Magazine "Lab Day Chicago 2013," 22-23 February.
Nobel Biocare is a world leader in implant-based restorations and a CAD/CAM pioneer as the first to offer fully automated industrial CAD/CAM...
Read More 4 minute read